Articles like this one from MSNBC show that the investment community is warming up to at least some regenerative and tissue engineering technologies required for future healthy life extension medicine. "Cellular Bioengineering has developed a process for growing corneal tissue, which may someday eliminate the need for human donors. It is creating a cell bank that would enable cells from one donor to generate enough supply for 1,000 recipients. ... The company expects to begin human clinical trials in 2006. An estimated 10 million people suffer from some type of corneal blindness, which can usually be cured by transplanting corneas from donors who have arranged to donate their organs after death."